22.5
China SXT Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
Assets
(positive)
Change from FY22 to FY26
millions USD
FY22:
FY23:
19.5
FY24:
14.2
FY25:
21.3
FY26:
34.5
(positive)
Change from FY22 to FY26
millions USD
FY22:
11.1
FY23:
10.0
FY24:
8.89
FY25:
0.37
FY26:
0.24
Total assets
Change from FY22 to FY26
millions USD
FY22:
33.5
FY23:
29.6
FY24:
23.1
FY25:
21.7
FY26:
34.8
Liabilities & Equity
(negative)
Change from FY22 to FY26
millions USD
FY22:
17.1
FY23:
14.5
FY24:
8.90
FY25:
6.01
FY26:
4.35
(negative)
millions USD
FY22:
0
FY23:
0.37
FY24:
0.29
FY25:
0.21
FY26:
0.70
(positive)
Change from FY22 to FY26
millions USD
FY22:
16.4
FY23:
14.7
FY24:
13.9
FY25:
15.4
FY26:
29.7
Total liabilities & equity
Change from FY22 to FY26
millions USD
FY22:
33.5
FY23:
29.6
FY24:
23.1
FY25:
21.7
FY26:
34.8
All amounts in millions USD